MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH treatment
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by Ansaar Rai (West Virginia University Rockefeller Neuroscience Institute, Morgantown, USA)—has produced fresh evidence on the benefits offered by middle meningeal artery (MMA) embolisation as an adjunct to the current standard of […]